We showed that the inhibition of caspase-2 expression resulted in decreased activation of caspase-9, -3 and -7 after taxane application in breast cancer cells which implies that caspase-2 plays the role of an apical caspase in these cells [20] (see Figure 8). The gene discussed is CASP2; the disease is breast carcinoma.